Log in

Relevant bibliographies by topics / Cancers du tube digestif / Journal articles

To see the other types of publications on this topic, follow the link: Cancers du tube digestif.

Journal articles on the topic 'Cancers du tube digestif'

Author: Grafiati

Published: 22 February 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cancers du tube digestif.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Camara, NLY, A. Barry, O. Koulibaly, HZ Maomy, LT Soumaoro, B. Traoré, and A. Touré. "Epidémiologie des cancers du tube digestif au service de chirurgie générale de l’hôpital national Ignace Deen." Journal Africain des Cas Cliniques et Revues 9, no. 1 (January 13, 2025): 1–7. https://doi.org/10.70065/2591.jaccrafri.001l011301.

Full text

Abstract:

Introduction : Les cancers digestifs sont des tumeurs malignes qui se développent au niveau du tube digestif et ses annexes. Le but de notre étude était de déterminer le profil sociodémographique, clinique, thérapeutique des cancers digestifs dans le service de Chirurgie Générale de l’hôpital National Ignace Deen. Méthodologie : IL s’agit d’une étude observationnelle rétrospective monocentrique d’une durée de 10 ans allant du 1er janvier 2013 au 31 décembre 2022 portant sur l’ensemble des malades admis et pris en charge dans le service de chirurgie générale pour un cancer du tube digestif. Résultats : Les cancers digestifs représentaient ainsi 3,87% de l’ensemble des activités du service. L’âge moyen de nos patients était de 52,4 ans avec un sex-ratio de 1,77. La symptomatologie clinique est dominée par la douleur abdominale (38,34%), l'amaigrissement (32,70%). L'adénocarcinome était le type histologique le plus fréquent (64,7%).45,5% des patientes se présentent dans un stade métastatique au moment de diagnostic. Le traitement est basé sur la chirurgie Conclusion : Les cancers digestifs étaient relativement fréquents dans notre contexte, dominés par les cancers colo-rectaux (30,7%). Les circonstances de découverte était dominé par la douleur abdominale accompagné d’une altération de l’état général. Sur le plan histologique, il s’agissait le plus souvent d’un adénocarcinome chez 172 patients (64,7%). La chirurgie a été le seul moyen utilisé, 168 patients (63,1%) ont été opérés dont 69 patients opérés en urgence et 99 en chirurgie réglée. Mots-clés : Cancers digestifs, épidémiologie, CHU Ignace Deen.

APA, Harvard, Vancouver, ISO, and other styles

2

Bouvier, A. M., C. Lepage, and J. Faivre. "Épidémiologie des cancers du tube digestif." EMC - Gastro-entérologie 4, no. 2 (January 2009): 1–8. http://dx.doi.org/10.1016/s1155-1968(09)50903-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Benhamiche-Bouvier, Anne-Marie, François Clinard, Vincent Dancourt, and Jean Faivre. "Épidémiologie des cancers du tube digestif." EMC - Gastro-entérologie 18, no. 3 (2001): 1–7. https://doi.org/10.1016/s1155-1968(01)00042-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Cottet, V., C. Bonithon-Kopp, and J. Faivre. "Prévention primaire des cancers du tube digestif." EMC - Gastro-entérologie 1, no. 1 (January 2006): 1–9. http://dx.doi.org/10.1016/s1155-1968(06)74157-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Cottet, V., C. Bonithon-Kopp, and J. Faivre. "Prévention primaire des cancers du tube digestif." EMC - Chirurgie 1, no. 1 (February 2004): 32–46. http://dx.doi.org/10.1016/j.emcchi.2003.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Cottet, V., C. Bonithon-Kopp, and J. Faivre. "Prévention primaire des cancers du tube digestif." EMC - Gastro-entérologie 21, no. 1 (2004): 1–10. https://doi.org/10.1016/s1155-1968(04)27457-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bentefouet, TL, MD Fall, A. Sow, MM Diop, and I. Thiam. "C36: Profil épidémiologique et anatomopathologique des polypes du tube digestif à Thiès (Sénégal) : A propos de 56 cas." African Journal of Oncology 2, no. 1 Supplement (March 1, 2022): S16. http://dx.doi.org/10.54266/ajo.2.1s.c36.wf4yqvyw4k.

Full text

Abstract:

INTRODUCTION : Le polype correspond à des lésions en relief dans la lumière du tube digestif. Certains polypes classés comme bénins peuvent évoluer vers des lésions dysplasiques, puis vers un cancer. L’objectif de ce travail était d’étudier les aspects épidémiologiques et anatomopathologiques des polypes du tube digestif à Thiès et d’évaluer la fréquence et le degré de dysplasie dans les différentes lésions observées. MATERIELS ET METHODES : Il s’agit d’une étude rétrospective sur une période de cinq ans (2016 à 2020). Les données ont été collectés à partir des dossiers des patients au niveau du laboratoire d’Anatomie Pathologique de la région de Thiès. Pour chaque patient, nous avons établi une fiche d’exploitation comportant l’âge, le sexe, les circonstances de découverte, le siège du polype, le nombre de polype, l’aspect macroscopique, et le type histologique. Les données ont été saisies et analysées par le logiciel Excel© 2010 et SPSS© 20. RESULTATS : Nous avons colligé au total 56 cas de polypes du tube digestif. Le sex-ratio était d’un. L’âge moyen était de 38 ± 24 ans (trois à 84 ans). Les épigastralgies et les rectorragies, constituaient les principales circonstances de découverte. Les polypes siégeaient préférentiellement au niveau de l’estomac et du colon. Les autres localisations étaient rares dans l’ensemble du tube digestif à des proportions variables. Il s’agissait le plus souvent de polypes uniques avec dans la majorité des cas, une taille supérieure ou égale à 10 mm (48% des cas). Les types histologiques étaient variés et les lésions dysplasiques étaient retrouvées dans six cas (10,7%). CONCLUSION : Le dépistage précoce des polypes dysplasiques permet de prévenir la survenue de certains cancers digestifs gastriques et colorectaux.

APA, Harvard, Vancouver, ISO, and other styles

8

Barret, M., B. Terris, and S. Chaussade. "Recommandations concernant les cancers superficiels du tube digestif. Partie 1 : règles générales de la prise en charge des cancers superficiels du tube digestif." Acta Endoscopica 47, no. 4 (April 25, 2017): 164–67. http://dx.doi.org/10.1007/s10190-017-0595-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Terris, Benoit, Bertrand Brieau, and Stanislas Chaussade. "Recommandations pour les cancers superficiels du tube digestif : cancer du côlon (CCR superficiels)." Acta Endoscopica 47, no. 4 (June 3, 2017): 168–73. http://dx.doi.org/10.1007/s10190-017-0596-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Lecomte, T., B. Godart, and G. Rahmi. "Recommandations : cancers superficiels du tube digestif. Prise en charge endoscopique des cancers superficiels de l’estomac." Acta Endoscopica 47, no. 4 (June 20, 2017): 180–86. http://dx.doi.org/10.1007/s10190-017-0599-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Ionescu, Vlad-Alexandru, Gina Gheorghe, Ruxandra Oprita, Madalina Stan-Ilie, Raluca-Ioana Dascalu, Ondin Zaharia, Viorel Jinga, Camelia Cristina Diaconu, and Gabriel Constantinescu. "The Outcomes of Nutritional Support Techniques in Patients with Gastrointestinal Cancers." Gastroenterology Insights 13, no. 3 (August 5, 2022): 245–57. http://dx.doi.org/10.3390/gastroent13030025.

Full text

Abstract:

Gastrointestinal cancers represent a major cause of morbidity and mortality worldwide. A significant issue regarding the therapeutic management of these patients consists of metabolic disturbances and malnutrition. Nutritional deficiencies have a negative impact on both the death rates of these patients and the results of surgical or oncological treatments. Thus, current guidelines recommend the inclusion of a nutritional profile in the therapeutic management of patients with gastrointestinal cancers. The development of digestive endoscopy techniques has led to the possibility of ensuring the enteral nutrition of cancer patients without oral feeding through minimally invasive techniques and the avoidance of surgeries, which involve more risks. The enteral nutrition modalities consist of endoscopy-guided nasoenteric tube (ENET), percutaneous endoscopic gastrostomy (PEG), percutaneous endoscopic gastrostomy with jejunal tube extension (PEG-J), direct percutaneous endoscopic jejunostomy (DPEJ) or endoscopic ultrasound (EUS)-guided gastroenterostomy.

APA, Harvard, Vancouver, ISO, and other styles

12

K, Ghebouli, Bendjoudi K, Larkem H, Kecir MA, and Belbekri M. "Video Assisted Thoracoscopy Talc Pleurodesis in the Management of Metastatic Pleural Effusion." EAS Journal of Medicine and Surgery 5, no. 10 (November 24, 2023): 197–201. http://dx.doi.org/10.36349/easjms.2023.v05i10.005.

Full text

Abstract:

Introduction: Metastatic pleural effusion complicates many cancers and impairs patients' quality of life. In a palliative situation, the decision between thoracoscopy talc pleurodesis, tube chest, iterative punctures or abstention is difficult and often operator dependent. Materials and methods: We report a study of 87 patients with metastatic pleural effusion treated by video assisted thoracoscopy talc pleurodesis. Results: Breast cancer constitutes the primary site causing metastatic pleural effusion in approximately half of cases, followed by bronchopulmonary cancers and finally digestive cancers. The complete response rate in the short and medium term is very satisfactory. We did not report any complications apart from one case of empyema. Conclusion: video assisted thoracoscopy talc pleurodesis constitutes an interesting treatment for recurrence of metastatic pleural effusion.

APA, Harvard, Vancouver, ISO, and other styles

13

Vella-Boucaud, J., D. Papathanassiou, O. Bouche, A. Prevost, T. Lestra, J. Nardi, J. M. Perotin, et al. "Fixations du tube digestif de découverte fortuite en TEP-TDM chez les patients suivis pour un cancer bronchopulmonaire." Revue des Maladies Respiratoires 32 (January 2015): A123. http://dx.doi.org/10.1016/j.rmr.2014.10.639.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Canard, J. M. "Prévention des complications des traitements endoscopiques des cancers superficiels du tube digestif supérieur et nécessité d’une surveillance étroite au-delà de cinq ans après la fin du traitement." Acta Endoscopica 45, no. 4 (June 2015): 193–94. http://dx.doi.org/10.1007/s10190-015-0477-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Seneviratne, Lasika, Steven Evans, Juvairiya Pulicharam, Nadir Arber, and Jacob Kuint. "Discovery of a core-panel of markers for a blood-assay for cancer detection utilizing cfDNA methylation changes." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 1522. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1522.

Full text

Abstract:

1522 Background: Cancer screening is limited to several cancers despite improved outcome A screening test should be acceptable, safe, and relatively inexpensive1 Tumors shed cfDNA to the blood where abundant tumor-specific methylation changes can be detected 1https://www.who.int/cancer/detection/variouscancer/en/. Methods: This is a prospective, multicenter, observational study under two protocols NCT04264767, NCT04264754. Plasma was collected from 1,255 subjects: 586 treatment-naïve cancer patients and 639 controls, in 21 sites and biobanks. Training set I (211 cases/99 controls) was used to select the 6 final markers for the core panel, training set II (200 controls) was used to lock the algorithm, and set the threshold to a score yielding specificity of 95%. The validation set (342 cases/310 controls) was performed utilizing the pre-specified algorithm and threshold. Plasma was separated from a single EDTA tube within 4 hours of blood draw. EpiCheck’s reagents and methylation-sensitive enzymes (Nucleix, Israel) were used for DNA extraction, digestion, and amplification in real-time PCR (ABI 7500 Fast Dx, Applied Biosystems). Results: Age was comparable but sex and smoking history were different (more women in cases, more smokers in controls). In the validation cohort twelve cancer types were included, with prominent representation of major cancer types (19% Breast, 14% colorectal and 21% lung) and stages I&II (56%). Specificity and sensitivity were maintained high at 94% and 62%. Highest sensitivity was demonstrated in GI cancers (77% colorectal, 83% esophageal, 100% gastric) and non-solid malignancies (83%). Sensitivity in early stage cancers (stages I, II & IIIA) was 71%, led by Sarcoma (83%) esophageal (76%) and colorectal (61%). Conclusions: This 6-marker blood-based methylation assay is a promising initial component in a future cancer screening test, generating significant signal in early cancers and utilizing simple and inexpensive PCR technology. Clinical trial information: NCT04264767, NCT04264754. [Table: see text]

APA, Harvard, Vancouver, ISO, and other styles

16

Boudghène-Stambouli, Frank, Gérard Schmutz, and Denis Régent. "Tube digestif." Journal de Radiologie 85, no. 9 (September 2004): 1280. http://dx.doi.org/10.1016/s0221-0363(04)76909-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Boudghène, Franck, Jean-Michel Bruel, and Catherine Ridereau-Zins. "Tube digestif." Journal de Radiologie 86, no. 10 (October 2005): 1295. http://dx.doi.org/10.1016/s0221-0363(05)75338-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Piva, MT, V. Sieso, A. Christopoulou, S. Lumbroso, P. Perney, H. Mion, and F. Blanc. "Intérêt de la phosphatase alcaline et de sa fraction H2 dans le diagnostic de métastases hépatiques d'un cancer du tube digestif." La Revue de Médecine Interne 15 (January 1994): 140s. http://dx.doi.org/10.1016/s0248-8663(05)82728-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Landolsi, A., I. Chabchoub, S. Limem, O. Gharbi, R. Chaafai, M. Hochlef, L. B. Fatma, et al. "Les lymphomes primitifs du tube digestif (LPTD) dans le centre tunisien : étude anatomoclinique et résultats thérapeutiques à propos de 153 cas." Bulletin du Cancer 97, no. 4 (April 2010): 435–43. http://dx.doi.org/10.1684/bdc.2010.1085.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Verduijn, Peter G. "Late Health Effects of Radiation for Eustachian Tube Dysfunction: Previous Results and Ongoing Study in the Netherlands." Otolaryngology–Head and Neck Surgery 115, no. 5 (November 1996): 417–21. http://dx.doi.org/10.1177/019459989611500510.

Full text

Abstract:

To study the late health effects of nasopharyngeal radium irradiation, a nonconcurrent prospective study was conducted in The Netherlands. Exposed subjects ( n = 2510) were treated unilaterally with nasopharyngeal radium irradiation at five ear, nose, and throat clinics between 1945 and 1965 and followed up through February 1, 1985. Unexposed subjects ( n = 2199) were matched to treated patients according to clinic, year of birth, and first consultation within 5 years. No overall significant increase in cancer mortality was found. A statistically significant difference was noted only for cumulative all-site cancer incidence, with the exposed having twice as many verified cancers as the nonexposed. This excess risk was caused mainly by head and neck tumors and other tumors flung, digestive tract, and urogenital system). The relative risk for these specific sites, however, was not significantly different from 1.00. These findings corroborate the hypothesis that there is some risk of tumor induction involved with nasopharyngeal radium irradiation at the dose level applied to this population. Because of ongoing interest in this subject, I plan to extend the follow-up of the cohort through December 31, 1995, and I am studying the possibility of expanding the study population.

APA, Harvard, Vancouver, ISO, and other styles

21

Buscarini, Elisabetta. "Tube digestif: pour." Acta Endoscopica 33, no. 1 (February 2003): 1–5. http://dx.doi.org/10.1007/bf03023666.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Stines, Joseph. "Tube digestif irradié." EMC - Radiologie et imagerie médicale - Abdominale - Digestive 15, no. 3 (1997): 1. https://doi.org/10.1016/s0246-0610(97)33315-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Shrotriya, Shiva, Calvin Abro, Fawzi Abu Rous, Rosemary Trimmer, Mukta Sharma, Supratik Rayamajhi, Bassam N. Estfan, and Declan Walsh. "Swallow screen and test in cancer patients." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e18288-e18288. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e18288.

Full text

Abstract:

e18288 Background: Swallowing is a complex process with four phases. It initiates digestion and is essential for proper nutrition. Difficulty swallowing independently correlated with cancer survival. We retrospectively evaluated the prevalence and incidence of difficulty swallowing in an acute care palliative medicine unit. BMI and survival were also examined. Methods: Electronic Medical Records (EMR) 2010-2012 was reviewed. Assessment comprised of 3 steps: nurse survey on patient condition (coma, intubation, PEG/feeing tube, respiratory distress), screening questionnaire and clinical swallowing test. Change in BMI from the day of admission to discharge calculated. Survival calculated from EMR and Social Security Death Index. Results: N = 261 with cancer identified; 47% known metastases. The mean age (± SD) was 68 ± 13 years. 55% females. 71% Caucasians and 25% African Americans. It was common in lung, gastrointestinal (GI) and genitourinary (GU) cancers. Clinical swallowing test was indicated in 94%. Prevalence of difficulty swallowing = 6%. Incidence of difficulty swallowing = 21%. Change in Body Mass Index (BMI) from 26 ± 7 (Mean ± SD) to 26 ± 6 on admission to discharge respectively. Median (25th, 75th percentile) survival: 25(13, 62) days. Conclusions: Difficulty swallowing was common in lung, GI and GU cancers. The incidence of difficulty swallowing in acute care palliative medicine unit was 21% and prevalence 6%. 75% with difficulty swallowing identified by nurse’s initial survey, 19% through screening questionnaires and 6% clinical swallowing test. Pneumonia/respiratory and GI problems were common. Swallowing evaluation critical for comprehensive cancer care.

APA, Harvard, Vancouver, ISO, and other styles

24

Quilliot, Didier, Niasha Michot, Lucie Germain, Justine Krier, Anthony Lopez, Laurent Bresler, Ahmet Ayav, Aurélie Malgras, and Phi-Linh Nguyen-Thi. "Feasibility, acceptability of enteral tube feeding and self-insertion of a nasogastric tube in the nutritional management of digestive cancers, impact on quality of life." Clinical Nutrition 39, no. 6 (June 2020): 1785–92. http://dx.doi.org/10.1016/j.clnu.2019.07.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Costache, M. I., Mihai Ioana, Sevastiţa Iordache, D. Ene, Cornelia Alexandra Costache, and A. Săftoiu. "VEGF expression in pancreatic cancer and other malignancies: a review of the literature." Romanian Journal Of Internal Medicine 53, no. 3 (September 1, 2015): 199–208. http://dx.doi.org/10.1515/rjim-2015-0027.

Full text

Abstract:

Abstract Angiogenesis is a crucial event for tumor growth and it is regulated predominantly by several different growth factors. Vascular endothelial growth factor protein family (VEGF) and its receptors are probably the most important tissue factors responsible for angioblast differentiation and tube formation. VEGF protein family currently comprises several members: VEGF (or VEGF-A), VEGF-B, VEGF-C and VEGF-D, VEGF-F, placental growth factor (PlGF), and their receptors VEGFR-1, VEGFR-2 and VEGFR-3. VEGF is a key angiogenic growth factor and its level of expression is a critical marker for detection of the angiogenic diseases. The potent role of VEGF in tumor angiogenesis has been widely described in the past decade, being expressed in most types of nondigestive and digestive cancers. VEGF family members play an important role in the development of pancreatic cancer (especially VEGF-A, VEGF-C, VEGF-D, VEGFR-1 and VEGFR-2). VEGF-A is the most specific and prominent angiogenic factor among all family members and VEGFR-2 is the most important receptor in evaluating the angiogenesis in pancreatic cancer. Thus, VEGF overexpression may be considered as a diagnostic marker and as a poor prognostic factor of the disease.

APA, Harvard, Vancouver, ISO, and other styles

26

Bogomoletz, Wladimir V. "Histopathologie du Tube Digestif." American Journal of Surgical Pathology 12, no. 10 (October 1988): 812. http://dx.doi.org/10.1097/00000478-198810000-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Faivre, Jamila, Christian Bréchot, and Nicolas Moniaux. "Communication foie/tube digestif." médecine/sciences 29, no. 11 (November 2013): 954–56. http://dx.doi.org/10.1051/medsci/20132911008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Gallix, Benoît. "IRM du tube digestif." Journal de Radiologie 88, no. 10 (October 2007): 1274. http://dx.doi.org/10.1016/s0221-0363(07)80656-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Aubé, Christophe. "Imagerie du tube digestif." Journal de Radiologie 88, no. 10 (October 2007): 1449. http://dx.doi.org/10.1016/s0221-0363(07)81382-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Adell, J. F., and S. Aufort. "Tumeur du tube digestif." Journal de Radiologie 89, no. 10 (October 2008): 1285. http://dx.doi.org/10.1016/s0221-0363(08)75827-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Carbonnel, Franck. "Tube digestif et pancréas." Gastroentérologie Clinique et Biologique 28, no. 3 (March 2004): 215–17. http://dx.doi.org/10.1016/s0399-8320(04)94885-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Blayac, Paul-Marie, Nicolas Kessler, Alvian Lesnik, Patrice Taourel, Franc¸ois-Michel Lopez, and Jean-Michel Bruel. "Traumatismes du tube digestif." EMC - Radiologie et imagerie médicale - Abdominale - Digestive 1, no. 1 (January 2006): 1–7. http://dx.doi.org/10.1016/s1879-8527(06)74702-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Regent, D., C. Balaj, F. Jausset, A. Oliver, C. Sellal-Aubriot, and V. Croise-Laurent. "Perforations du tube digestif." EMC - Radiologie et imagerie médicale - Abdominale - Digestive 7, no. 4 (December 2012): 1–21. http://dx.doi.org/10.1016/s1879-8527(12)59309-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Descos, L. "Cytomegalovirus et tube digestif." Médecine et Maladies Infectieuses 18 (March 1988): 42–43. http://dx.doi.org/10.1016/s0399-077x(88)80092-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Descos, L. "Cytomegalovirus et tube digestif." Médecine et Maladies Infectieuses 18, no. 12 (December 1988): 863–68. http://dx.doi.org/10.1016/s0399-077x(88)80242-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Ruskoné-Fourmestraux, A. "Lymphomes du tube digestif." EMC - Traité de médecine AKOS 8, no. 2 (April 2013): 1–7. http://dx.doi.org/10.1016/s1634-6939(13)62156-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Adell, J. F., and S. Aufort. "Tumeur du tube digestif." Journal de Radiologie 90, no. 10 (October 2009): 1364. http://dx.doi.org/10.1016/s0221-0363(09)75391-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Ruskoné-Fourmestraux, A., B. Fabiani, and C. Thieblemont. "Lymphomes du tube digestif." EMC - Gastro-entérologie 8, no. 1 (January 2013): 1–13. http://dx.doi.org/10.1016/s1155-1968(12)46614-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Ruskoné-Fourmestraux, A., C. Thieblemont, and B. Fabiani. "Lymphomes du tube digestif." EMC - Hématologie 8, no. 2 (May 2013): 1–13. http://dx.doi.org/10.1016/s1155-1984(13)60050-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Valette, P. J., and Y. Menard. "Tomodensitométrie du tube digestif." Acta Endoscopica 27, no. 4 (July 1997): 351–53. http://dx.doi.org/10.1007/bf02968706.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Regent, Denis, Clémence Balaj, François Jausset, Alexandre Oliver, Caroline Sellal-Aubriot, and Valérie Croise-Laurent. "Perforations du tube digestif." Feuillets de Radiologie 54, no. 1 (February 2014): 9–31. http://dx.doi.org/10.1016/j.frad.2014.01.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Amatore, F., and E. Delaporte. "Peau et tube digestif." EMC - Dermatologie 25, no. 2 (May 2023): 1–10. https://doi.org/10.1016/s0246-0319(22)43968-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Blayac, Paul-Marie, Nicolas Kessler, Alvian Lesnik, Patrice Taourel, François-Michel Lopez, and Jean-Michel Bruel. "Traumatismes du tube digestif." EMC - Radiologie et imagerie médicale - Abdominale - Digestive 20, no. 4 (2002): 1–8. https://doi.org/10.1016/s0246-0610(02)00045-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Palazzo, Laurent, Gilles Roseau, Jean Vitaux, and Joseph-Antoine Paolaggi. "Endosonographie du tube digestif." EMC - Gastro-entérologie 12, no. 2 (1995): 1. https://doi.org/10.1016/s1155-1968(95)09677-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Agarwal, Shashi K. "Lifestyles and their Close Relationship with Gastrointestinal Diseases (Part I: Diet)." East African Scholars Journal of Medical Sciences 5, no. 2 (February 18, 2022): 49–57. http://dx.doi.org/10.36349/easms.2022.v05i02.005.

Full text

Abstract:

The gastrointestinal tract (GI) is a continuous hollow twisting tube from the mouth to the anus. Its hollow organs include the mouth, esophagus, stomach, small intestine, large intestine, and anus. The liver, pancreas, and gallbladder (solid organs) are also considered part of the GI tract. The principal functions of the GI tract are digestion, absorption, excretion, and protection. Digestion and absorption occur primarily in the stomach and small intestine. Desiccation and compaction of waste occur in the large intestine. The waste products are then stored in the sigmoid colon and rectum before their elimination. The GI tract is influenced by several lifestyles, including the amount and the composition of the diet. The macronutrients and micronutrients in the diet, if prudent, are important for maintaining good GI health. However, unhealthy choices may cause or influence the development of GI pathology (such as esophageal reflux, peptic ulcer, inflammatory bowel disease, dietary intolerance, or even GI cancers). The lifestyle GI connection is reviewed in this two-part manuscript.

APA, Harvard, Vancouver, ISO, and other styles

46

Zarin, Bahare, Laleh Rafiee, Parnaz Daneshpajouhnejad, and Shaghayegh Haghjooy Javanmard. "A review on the role of CAFs and CAF-derived exosomes in progression and metastasis of digestive system cancers." Tumor Biology 43, no. 1 (August 18, 2021): 141–57. http://dx.doi.org/10.3233/tub-200075.

Full text

Abstract:

Cancers evolve as a result of the accelerated proliferation of cancer cells in a complicated, enriched, and active microenvironment. Tumor microenvironment (TME) components are the master regulators of any step of cancer development. The tumor microenvironment is composed of many cellular and noncellular components that contribute to the evolution of cancer cells. Cancer-associated fibroblasts (CAFs) are activated fibroblasts in the TME that implicate in tumor progression and metastasis dissemination through secretion of oncogenic factors which are carried to the secondary metastatic sites through exosomes. In this review, we aimed to assess the role of CAF-derived exosomes in TME construction and pre-metastatic niche formation in different cancers of the digestive system in order to better understand some important mechanisms of metastasis and provide possible targets for clinical intervention. This review article is divided into two thematic parts explaining the general mechanisms of pre-metastatic niche formation and metastasis and the role of CAF-derived exosomes in different digestive system cancers including colorectal, gastric, esophageal, pancreatic, and liver cancers.

APA, Harvard, Vancouver, ISO, and other styles

47

Maunoury, Vincent, Caroline Degrugillier-Chopinet, and Brigitte Jude. "Malformations vasculaires du tube digestif." Sang thrombose vaisseaux 22, no. 7 (September 2010): 383–88. http://dx.doi.org/10.1684/stv.2010.0506.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Molkhou, P. "Allergie alimentaire et tube digestif." Revue Française d'Allergologie 55, no. 7 (November 2015): 436–37. http://dx.doi.org/10.1016/j.reval.2015.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Nahon, S., and Y. Bouhnik. "Vascularites, collagénoses et tube digestif." EMC - Gastro-entérologie 1, no. 1 (January 2006): 1–6. http://dx.doi.org/10.1016/s1155-1968(04)27492-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Baju, Alice, Xavier Causse, Xavier Coutouly, Fréderic Maitre, Patrick Michenet, Bernadette Berland-dai, and Pascal Potier. "Schwannomes multiples du tube digestif." Gastroentérologie Clinique et Biologique 30, no. 4 (April 2006): 632–35. http://dx.doi.org/10.1016/s0399-8320(06)73247-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!